Prof. Dr. med. Eicke Latz

2001
Doctorate, Medicine (Dr. med.), Free University of Berlin, Berlin, Germany

1998
German Medical Licence Examination (State examination), License to practice Medicine (Approbation), Berlin, Germany

1995 – 2000
US Medical Licence Examinations I, II, III, Educational Commission for Foreign Medical Graduates, Philadelphia, USA

1991 – 1998
Studies of Medicine, Georg-August-University Göttingen and Free University of Berlin, Berlin, Germany

05/2023
Scientific Director, Deutsches Rheuma Forschungszentrum Berlin (DRFZ)

05/2023
Professor of Experimental Rheumatology (W3), Charité, Berlin, Germany

2013
Full Professor of Medicine, Division of Infectious Diseases and Immunology, UMass Medical School, Worcester, MA, USA

2011
Group leader, Innate Immunity in Neurodegeneration, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany

2009
Professor of Medicine (W3), Founder and Co-Director, Institute of Innate Immunity, Medical Faculty/University Hospital, University of Bonn, Germany

2008
Adjunct Professor II, Center for Molecular Inflammation Research (CEMIR), Norwegian University of Science and Technology, Trondheim, Norway

2006 – 2013
Assistant Professor of Medicine, Division of Infectious Diseases and Immunology, UMass Medical School, Worcester, MA, USA

2003 – 2006
Research Assistant Professor of Medicine, Division of Infectious Diseases and Immunology, UMass Medical School, Worcester, MA, USA

2001 – 2003
Postdoctoral Fellow, Division of Infectious Diseases and Immunology, UMass Medical School, Worcester, MA, USA

1999 – 2001
Research Fellow, Molecular Sepsis Research Laboratories, Humboldt-University, Berlin, Germany

1998 – 2001
Internship and Residency (Intensive Care), Department of Surgery, Charité University Hospital, Berlin, Germany

1998
Visiting Scientist, Department of Lipid Biochemistry, Merck Research Laboratories, Rahway, NJ, USA 

2018 Gottfried-Wilhelm Leibniz-Prize; 2016 Elected Member, German National Academy of Sciences (Leopoldina); 2014-21 Highly Cited Researcher in Immunology, ‘World’s Most Influential Scientific Minds’ (Thomson Reuters); 2014 Kavli Fellow, United States National Academy of Sciences (NAS); 2011 Glaxo Smith Kline Clinical Science Award; 2009 Dana Foundation Award; 2004 FOCIS Award; 2001 DAAD Postdoctoral Grant

2009 – date
Institute of Innate Immunity, University of Bonn, Germany: 12 Postdocs, 32 Ph.D. students and 50 Master or Medical students

2006 – 2009
Department of Infectious Diseases and Immunology, UMass Medical School, Worcester, MA, USA: 4 Postdocs, 1 Ph.D. student, 7 Master’s or Medical students

2013 – 2017
“Studienstiftung” foundation, Bonn, Germany: Student courses “Innate Immunity”

2009 – date
University of Bonn, Germany: Master program “Medical Immunosciences and Infection’ (since 2016); Bachelor & Master programs ‘Immunobiology” (since 2009), Mentor student’s exchange program Waseda University, Japan (since 2009); Mentor “Bonn and Melbourne International Research & Training Group” (since 2016)

2009 – date
Norwegian University of Science and Technology, Trondheim, Norway: “Advanced Imaging Techniques and Molecular Imaging” (yearly)

2004 – date
UMass Medical School, Worcester, MA, USA: “Immunology and Virology” program

2002 – 2009
Yale University, New Haven, CT, USA: ‘Imaging Techniques / Molecular Imaging’

2024
Symposium “From Innate to Adaptive Immunity – a question of memory”, Berlin, Germany

2020 – 2024
2nd, 3rd and 4th “Immuno-Metabolic Mechanisms of Atherosclerosis Conference”, Nassau (The Bahamas), and Riviera Maya (Mexico)

2016
eystone Meeting “Myeloid Cells”, Killarney, Ireland
2014, 2017     Innate Immune Memory Conferences, Wellcome Trust, Cambridge, UK
2004 – 2024 Toll Meetings: Rotterdam, The Netherlands (2024); Porto, Portugal (2018); Marbella, Spain (2015); Riva del Garda, Italy (2011); Cascais/Lisbon, Portugal (2008); Taormina, Italy (2004)

2021 – 2023
Elected Member, Supervisory Board of the University of Bonn (‘Hochschulrat’)

2021 – 2023
Speaker, SFB 1454 “Metaflammation and Cellular Programming”, University of Bonn
2018 – 2023   Co-Speaker, Cluster of Excellence “ImmunoSensation2”, University of Bonn

2010 – 2023
Commissions Head: BONFOR (intramural funding), Research Infrastructure; Commissions Member: Personnel & Strategy, Finance, Core facilities; University of Bonn

2023 – date
Portfolio Advisory Board (PAB) Member, IBT Lower Saxony, Germany

2022 – date
Mentor, Creative Destruction Lab (CDL)-Berlin, European School of Management and Technology (ESMT) Berlin, Germany

2022 – date
ERC Panel Member, ERC starting grants, LS6 – Immunity, Infection and Immunotherapy

2021 – date
Co-Founder and Consultant, Odyssey Therapeutics, Boston, MA, USA

2020 – date
Co-Founder, Chairman of the Board, Dioscure SE, Bonn, Germany

2020 – date
Co-Founder, Chairman SAB, Board member, Stealth Biotech B-Corp, LA, CA, USA

2016 – date
Member, Helmholtz Think Tank, Helmholtz Society, Berlin

2016 – date
Co-Founder and Consultant, IFM Therapeutics LLC, Boston, MA, USA

2015 – date
Chair of Scientific Advisory Board, MPI for Infection Biology, Berlin, Germany

2008 – date
Consultant (current and past): Novartis (Basel, Switzerland); Glaxo Smith Kline (London, UK); Medimmune (Gaithersburg, MD, USA); Biogen (Cambridge, MA, USA); Amgen (Seattle, WA, USA); Eisai Pharmaceuticals (Andover, MA, USA); Altana Pharmaceuticals (Konstanz, Germany); CBio Pharmaceuticals (Brisbane, Australia); Johnson & Johnson (Brussels, Belgium); Boehringer (Ingelheim, Germany)

2008 – 2016
Member of Therapeutic Area Scientific Advisory Panels (TASAP): Inflammation & Immunology, Centers for Therapeutic Innovation, Pfizer (Cambridge, MA, USA)

2005 – date
Member of Advisory Boards (current and past): Pfizer Worldwide R & D (New York, NY, USA); Grünenthal Pharmaceuticals (Aachen, Germany); Genzyme (Boston, MA, USA); Opsona Pharmaceuticals (Dublin, Ireland)

2015
German Society for Immunology (DGFI), Member

2012
American Association of Immunologists (AAI), Member

2010
International Trained Immunity Consortium (INTRIM), Founding member